Efficacy of Tolterodine versus Oxybutynin in treatment of enuresis
Phase 2
Recruiting
- Conditions
- octural enuresis.Unspecified urinary incontinence
- Registration Number
- IRCT20141224020419N3
- Lead Sponsor
- Sari University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 61
Inclusion Criteria
Primary enuresis
No evidence of secondary enuresis in clinical examination, urine analysis and sonography
No response to nasal desmopressine
Exclusion Criteria
Secondary enuresis
Underlying genitourinary system anomalies
Interruption of follow up of the patient
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method octural enuresis in night. Timepoint: Beginning of the study, 6 and 12 weeks after beginning of the study. Method of measurement: The frequency of wetting every night.;Noctural enuresis in week. Timepoint: Beginning of the study, 6 and 12 weeks after beginning of the study. Method of measurement: The frequency of wetting in week.
- Secondary Outcome Measures
Name Time Method